Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown120%
completed360%
not_yet_recruiting120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder

NCT07570108
completed

Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

NCT06466447
completed

Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

NCT04701372
completedphase_1

Cannabinoid Medication for Adults With OCD

NCT02911324
unknownnot_applicable

Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder

NCT02602886

Clinical Trials (5)

Showing 5 of 5 trials
NCT07570108Not Applicable

Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder

Not Yet Recruiting
NCT06466447

Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

Completed
NCT04701372

Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

Completed
NCT02911324Phase 1

Cannabinoid Medication for Adults With OCD

Completed
NCT02602886Not Applicable

Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5